MAECELL Trademark

Trademark Overview

On Monday, August 10, 2020, a trademark application was filed for MAECELL with the United States Patent and Trademark Office. The USPTO has given the MAECELL trademark a serial number of 90103717. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, November 5, 2024. This trademark is owned by Genani Corporation. The MAECELL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, pharmaceutical preparations for repair of organs damaged by trauma, burns, drugs, radiation, hypoxia, and explosive device; pharmaceuticals, namely, pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for treating degenerative diseases and disorders of joints, heart, cardiovascular system, brain, spinal cord, ligaments, muscles, kidneys, liver, skin and lungs; pharmaceutical preparations for treatment of connective tissue diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal related diseases and disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of cardiovascular related diseases or disorders; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations fo...
maecell

General Information

Serial Number90103717
Word MarkMAECELL
Filing DateMonday, August 10, 2020
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, November 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2022

Trademark Statements

Goods and ServicesPharmaceuticals, namely, pharmaceutical preparations for repair of organs damaged by trauma, burns, drugs, radiation, hypoxia, and explosive device; pharmaceuticals, namely, pharmaceutical preparations for reversing effects of aging; pharmaceutical preparations for the prevention and treatment of autoimmune diseases or disorders; pharmaceutical preparations for treating degenerative diseases and disorders of joints, heart, cardiovascular system, brain, spinal cord, ligaments, muscles, kidneys, liver, skin and lungs; pharmaceutical preparations for treatment of connective tissue diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal related diseases and disorders; pharmaceutical preparations for the prevention and treatment of vascular diseases or disorders; pharmaceutical preparations for the treatment of cardiovascular related diseases or disorders; pharmaceutical preparations for the treatment of neurological disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treatment of cardiopulmonary and pulmonary related diseases and disorders; pharmaceutical preparations for use in skin care; astringents for medicinal purposes; pharmaceutical skin lotions; stem cells for medical purposes
Pseudo MarkMAE CELL

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 10, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGenani Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChicago, IL 60611
Party NameGenani Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChicago, IL 60611

Trademark Events

Event DateEvent Description
Thursday, August 13, 2020NEW APPLICATION ENTERED
Thursday, September 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 3, 2020ASSIGNED TO EXAMINER
Wednesday, December 9, 2020NON-FINAL ACTION WRITTEN
Wednesday, December 9, 2020NON-FINAL ACTION E-MAILED
Wednesday, December 9, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 8, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 9, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 9, 2021NON-FINAL ACTION E-MAILED
Wednesday, June 9, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 23, 2021NON-FINAL ACTION WRITTEN
Thursday, December 23, 2021NON-FINAL ACTION E-MAILED
Thursday, December 23, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 1, 2022TEAS PETITION TO REVIVE RECEIVED
Friday, July 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 6, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, July 6, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, July 6, 2022PETITION TO REVIVE-GRANTED
Wednesday, July 6, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, July 21, 2022ASSIGNED TO LIE
Thursday, July 21, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 21, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 5, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 5, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 24, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 13, 2022PUBLISHED FOR OPPOSITION
Tuesday, September 13, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, May 5, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 30, 2023SOU EXTENSION 2 FILED
Friday, May 5, 2023SOU EXTENSION 1 FILED
Friday, May 5, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 30, 2023SOU EXTENSION 2 GRANTED
Wednesday, November 1, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 18, 2024SOU EXTENSION 3 FILED
Thursday, April 18, 2024SOU EXTENSION 3 GRANTED
Friday, April 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, November 5, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 5, 2024SOU EXTENSION 4 FILED
Tuesday, November 5, 2024SOU EXTENSION 4 GRANTED

Related Keywords

maecell preparations pharmaceutical disorders diseases treatment cardiovascular prevention pharmaceuticals namely related